Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|Cellectar Receives FDA Fast Track Design...||07/09/19|
|FLORHAM PARK, N.J., July 09, 2019 -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a clinical-stage biopharmaceutical company focused on the discovery, ...|
|Date||2019-05-06 (BMO)||Est. (EPS/Rev.)||($0.74)/ 0|
|Actual (EPS/Rev.)||$-0.76/||EPS (TTM)||0|